These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 16249257)
1. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets. Ishiyama N; Ravier MA; Henquin JC Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E540-9. PubMed ID: 16249257 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological approach to understanding the control of insulin secretion in human islets. Henquin JC; Dufrane D; Gmyr V; Kerr-Conte J; Nenquin M Diabetes Obes Metab; 2017 Aug; 19(8):1061-1070. PubMed ID: 28116849 [TBL] [Abstract][Full Text] [Related]
3. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells. Mariot P; Gilon P; Nenquin M; Henquin JC Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741 [TBL] [Abstract][Full Text] [Related]
4. Activators of PKA and Epac distinctly influence insulin secretion and cytosolic Ca2+ in female mouse islets stimulated by glucose and tolbutamide. Henquin JC; Nenquin M Endocrinology; 2014 Sep; 155(9):3274-87. PubMed ID: 24977470 [TBL] [Abstract][Full Text] [Related]
5. Effect of 17beta-estradiol on insulin secretion and cytosolic calcium in Min6 mouse insulinoma cells and human islets of Langerhans. Al-Majed HT; Squires PE; Persaud SJ; Huang GC; Amiel S; Whitehouse BJ; Jones PM Pancreas; 2005 May; 30(4):307-13. PubMed ID: 15841038 [TBL] [Abstract][Full Text] [Related]
6. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells. Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197 [TBL] [Abstract][Full Text] [Related]
7. Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: evidence supporting specific desensitization rather than beta-cell exhaustion. Davalli AM; Pontiroli AE; Socci C; Bertuzzi F; Fattor B; Braghi S; Di Carlo V; Pozza G J Clin Endocrinol Metab; 1992 Apr; 74(4):790-4. PubMed ID: 1548342 [TBL] [Abstract][Full Text] [Related]
8. The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse islets. Hermans MP; Schmeer W; Henquin JC Diabetologia; 1987 Aug; 30(8):659-65. PubMed ID: 3308605 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Pfeifer MA; Halter JB; Graf R; Porte D Diabetes; 1980 May; 29(5):335-40. PubMed ID: 6991327 [TBL] [Abstract][Full Text] [Related]
10. Effects of glucose, forskolin and tolbutamide on membrane potential and insulin secretion in the insulin-secreting cell line INS-1. Ullrich S; Abel KB; Lehr S; Greger R Pflugers Arch; 1996 Aug; 432(4):630-6. PubMed ID: 8764963 [TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator. Johnson D; Shepherd RM; Gill D; Gorman T; Smith DM; Dunne MJ Diabetes; 2007 Jun; 56(6):1694-702. PubMed ID: 17360975 [TBL] [Abstract][Full Text] [Related]
12. Alterations of insulin response to different beta cell secretagogues and pancreatic vascular resistance induced by N omega-nitro-L-arginine methyl ester. Gross R; Roye M; Manteghetti M; Hillaire-Buys D; Ribes G Br J Pharmacol; 1995 Oct; 116(3):1965-72. PubMed ID: 8640333 [TBL] [Abstract][Full Text] [Related]
13. Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice. Hamada Y; Ikegami H; Ueda H; Kawaguchi Y; Yamato E; Nojima K; Yamada K; Babaya N; Shibata M; Ogihara T Metabolism; 2001 Nov; 50(11):1282-5. PubMed ID: 11699045 [TBL] [Abstract][Full Text] [Related]
14. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies. Rustenbeck I; Dickel C; Grimmsmanns T Biochem Pharmacol; 2001 Dec; 62(12):1695-703. PubMed ID: 11755123 [TBL] [Abstract][Full Text] [Related]
15. Tolbutamide stimulation of pancreatic beta-cells involves both cell recruitment and increase in the individual Ca(2+) response. Jonkers FC; Guiot Y; Rahier J; Henquin JC Br J Pharmacol; 2001 Jun; 133(4):575-85. PubMed ID: 11399675 [TBL] [Abstract][Full Text] [Related]
16. Beta-cell memory to insulin secretagogues: characterization of the time-dependent inhibitory control system in the isolated rat pancreas. Nesher R; Eylon L; Segal N; Cerasi E Endocrinology; 1989 Jan; 124(1):142-8. PubMed ID: 2462485 [TBL] [Abstract][Full Text] [Related]
17. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content. Anello M; Gilon P; Henquin JC Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920 [TBL] [Abstract][Full Text] [Related]
18. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells. Sato Y; Anello M; Henquin JC Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978 [TBL] [Abstract][Full Text] [Related]
19. L-arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide. Thams P; Capito K Eur J Endocrinol; 1999 Jan; 140(1):87-93. PubMed ID: 10037257 [TBL] [Abstract][Full Text] [Related]